CELLDEX THERAPEUTICS INC NEW's ticker is CLDX and the CUSIP is 15117B202. A total of 130 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q4 2020. The put-call ratio across all filers is 0.95 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $13,042,278 | -21.2% | 473,920 | -2.8% | 0.00% | 0.0% |
Q2 2023 | $16,549,425 | -4.3% | 487,752 | +1.5% | 0.00% | 0.0% |
Q1 2023 | $17,290,297 | -10.7% | 480,553 | +10.6% | 0.00% | -25.0% |
Q4 2022 | $19,370,656 | +63.2% | 434,612 | +2.9% | 0.00% | +33.3% |
Q3 2022 | $11,869,000 | +3.9% | 422,241 | -0.3% | 0.00% | +50.0% |
Q2 2022 | $11,422,000 | -23.7% | 423,667 | -3.6% | 0.00% | -33.3% |
Q1 2022 | $14,970,000 | -16.5% | 439,534 | -5.3% | 0.00% | 0.0% |
Q4 2021 | $17,936,000 | -27.6% | 464,164 | +1.1% | 0.00% | -25.0% |
Q3 2021 | $24,788,000 | +79.8% | 459,113 | +11.4% | 0.00% | +100.0% |
Q2 2021 | $13,786,000 | +524.1% | 412,263 | +284.6% | 0.00% | – |
Q1 2021 | $2,209,000 | +32.8% | 107,206 | +12.9% | 0.00% | – |
Q4 2020 | $1,664,000 | +26.9% | 94,989 | +7.5% | 0.00% | – |
Q3 2020 | $1,311,000 | +76.2% | 88,345 | +54.2% | 0.00% | – |
Q2 2020 | $744,000 | +1205.3% | 57,300 | +67.3% | 0.00% | – |
Q1 2020 | $57,000 | -26.9% | 34,260 | -0.9% | 0.00% | – |
Q4 2019 | $78,000 | +23.8% | 34,581 | +17.5% | 0.00% | – |
Q3 2019 | $63,000 | -18.2% | 29,427 | +1.8% | 0.00% | – |
Q2 2019 | $77,000 | -44.6% | 28,898 | +2.4% | 0.00% | – |
Q1 2019 | $139,000 | – | 28,210 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Kynam Capital Management, LP | 3,200,000 | $88,064,000 | 14.40% |
Octagon Capital Advisors LP | 759,898 | $20,912,393 | 3.21% |
TSP Capital Management Group, LLC | 251,695 | $6,926,645 | 2.67% |
5AM Venture Management, LLC | 310,270 | $8,538,630 | 2.46% |
COMMODORE CAPITAL LP | 706,665 | $19,447,421 | 2.27% |
ACUTA CAPITAL PARTNERS, LLC | 122,341 | $3,366,824 | 2.26% |
Redmile Group, LLC | 1,635,938 | $45,021,014 | 2.14% |
RTW INVESTMENTS, LP | 3,463,201 | $95,307,292 | 2.01% |
Eversept Partners, LP | 588,143 | $16,185,695 | 1.37% |
Affinity Asset Advisors, LLC | 150,000 | $4,128,000 | 1.16% |